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Binding of p53 to miR-34a promoter activates the expres-
sion of tumor suppressive miR-34a. Our previous study
demonstrated that oncogenic HPV infection downregu-
lates miR-34a expression through degradation of p53
mediated by E6. In searching for miR-34a targets, we
found that miR-34a mainly downregulates p18Ink4c, a
CDK4/6 inhibitor induced by E2F transactivation.
HPV18+ HeLa cells with ectopic miR-34a expression or
by E6 siRNA knockdown-induced expression of miR-34a
had a substantially reduced expression of p18Ink4c in a
dose-dependent manner, but had no effect on p16Ink4a,
a n o t h e rm e m b e ro fC D K 4 / 6i n h i b i t o rf a m i l y .F u r t h e r
investigation showed an increased p18Ink4c level in cer-
vical cancer tissues by western blotting as compared to
normal cervix. By immunostaining of tissue arrays, an
increased expression of p18Ink4c was found in 68% of
cervical cancer tissues, but only in 6.6% of normal cervi-
cal tissues. Moreover, specific inhibition of miR-34a
expression in CaSki cells promoted the expression of
p18Ink4c. Raft cultures with HPV16 or HPV18 infections
also showed an increased p18Ink4c expression. In a
reporter assay, we demonstrated that disruption of the
miR-34a seed match from p18Ink4c promoted luciferase
activity in the presence of ectopic miR-34a. As a cell
cycle regulatory protein in normal cells, the increased
p18Ink4c expression by E6-induced p53 destabilization
and miR-34a reduction in cervical cancer would lead to
suppress cell cycling and proliferation. However, viral E7
expressed in cervical cancer cells inactivates pRB and
disassociates E2F from pRB, resulting in disruption of
normal G1 checkpoint. Thus, an increased p18Ink4c in
the cervical cancer cells would not affect the cell growth.
To test this hypothesis, we knocked down p18Ink4c
expression by siRNA in both HPV18-positive HeLa cells
and HPV-negative HCT116 cells, a colon cancer cell line
that contains an intact G1 checkpoint. As we predicted,
knocking down p18Ink4c expression promoted the
growth of HCT116 cells but had no effect on HeLa cells.
Altogether, our data indicate that p18Ink4c is a miR-34a
target and its increased expression in cervical cancer
tissues can be used as a new biomarker for cervical can-
cer diagnosis and prognosis.
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